Updates are available Correction dated 2024-09-26
Click to view Correction: https://doi.org/10.1007/s11910-024-01380-9
-
Authors
Rjeily, Nicole Bou
Solomon, Andrew J.
- License Information
-
More Information
Article History
Accepted: 13 August 2024
First Online: 7 September 2024
Change Date: 26 September 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11910-024-01380-9
Declarations
:
: N.B.R.: No relationships to disclose. A.J.S.: Consulting for Octave Bioscience and Kiniksa Pharmaceuticals. Served on advisory board for TG Therapeutics, Horizon Therapeutics and Bristol Meyers Squibb. Provided non-promotional Speaking for EMD Serono. Site PI for contract research for Sanofi, Actelion, Genentech/Roche, Novartis. Received research funding from Bristol Meyers Squibb.
: NBR: No relationships to disclose.
: AJS: Consulting for Octave Bioscience and Kiniksa Pharmaceuticals. Served on advisory board for TG Therapeutics, Horizon Therapeutics and Bristol Meyers Squibb. Provided non-promotional Speaking for EMD Serono. Site PI for contract research for Sanofi, Actelion, Genentech/Roche, Novartis. Received research funding from Bristol Meyers Squibb.
